| [1] |
Markowitz GS, Lin J, Valeri AM, et al. Idiopathic nodular glomerulosclerosis is a distinct clinicopathologic entity linked to hypertension and smoking [J]. Hum Pathol, 2002, 33(8): 826-835.
|
| [2] |
Wu J, Yu S, Tejwani V, et al. Idiopathic nodular glomerulosclerosis in Chinese patients: a clinicopathologic study of 20 cases [J]. Clin Exp Nephrol, 2014, 18(6): 865-875.
|
| [3] |
Kimmelstiel P, Wilson C. Intercapillary lesions in the glomeruli of the kidney [J]. Am J Pathol, 1936, 12(1): 83-98.
|
| [4] |
Nasr SH, D′Agati VD. Nodular glomerulosclerosis in the nondiabetic smoker [J]. J Am Soc Nephrol, 2007, 18(7): 2032-2036.
|
| [5] |
Alpers CE, Biava CG. Idiopathic lobular glomerulonephritis (nodular mesangial sclerosis): a distinct diagnostic entity [J]. Clin Nephrol, 1989, 32(2): 68-74.
|
| [6] |
Li W, Verani RR. Idiopathic nodular glomerulosclerosis: a clinicopathologic study of 15 cases [J]. Hum Pathol, 2008, 39(12): 1771-1776.
|
| [7] |
Siraj ES, Myles J, Nurko S, et al. Development of diabetes mellitus several years after manifestation of diabetic nephropathy: case report and review of literature [J]. Endocr Pract, 2003, 9(4): 301-306.
|
| [8] |
Orth SR. Smoking and the kidney [J]. J Am Soc Nephrol, 2002, 13(6): 1663-1672.
|
| [9] |
Elliot SJ, Karl M, Berho M, et al. Smoking induces glomerulosclerosis in aging estrogen-deficient mice through cross-talk between TGF-beta1 and IGF-I signaling pathways [J]. J Am Soc Nephrol, 2006, 17(12): 3315-3324.
|
| [10] |
Cryer PE, Haymond MW, Santiago JV, et al. Norepinephrine and epinephrine release and adrenergic mediation of smoking-associated hemodynamic and metabolic events [J]. N Engl J Med, 1976, 295(11): 573-577.
|
| [11] |
Tanji N, Markowitz GS, Fu C, et al. Expression of advanced glycation end products and their cellular receptor RAGE in diabetic nephropathy and nondiabetic renal disease [J]. J Am Soc Nephrol, 2000, 11(9): 1656-1666.
|
| [12] |
Yan SD, Schmidt AM, Anderson GM, et al. Enhanced cellular oxidant stress by the interaction of advanced glycation end products with their receptors/binding proteins [J]. J Biol Chem, 1994, 269(13): 9889-9897.
|
| [13] |
Sanai T, Okuda S, Yoshimitsu T, et al. Nodular glomerulosclerosis in patients without any manifestation of diabetes mellitus [J]. Nephrology, 2007, 12(1): 69-73.
|
| [14] |
Wolf G, Chen SD, Ziyadeh FN. Leptin and renal disease [J]. Am J Kidney Dis, 2002, 39(1): 1-11.
|
| [15] |
Esposito K, Nappo F, Marfella R, et al. Inflammatory cytokine concentrations are acutely increased by hyperglycemia in humans [J]. Circulation, 2002, 106(16): 2067-2072.
|
| [16] |
Chagnac A, Weinstein T, Korzets A, et al. Glomerular hemodynamics in severe obesity [J]. Am J Physiol Renal Physiol, 2000, 278(5): F817-F822.
|
| [17] |
D′Agati VD, Markowitz GS. Supersized kidneys: lessons from the preclinical obese kidney [J]. Kidney Int, 2008, 73(8): 909-910.
|
| [18] |
Geroldi D, Falcone C, Emanuele E, et al. Decreased plasma levels of soluble receptor for advanced glycation end-products in patients with essential hypertension [J]. J Hypertens, 2005, 23(9): 1725-1729.
|
| [19] |
Araujo LS, Queiroz AA, Monteiro ML, et al. Nodular glomerulosclerosis in a non-diabetic hypertensive, dyslipidemic, smoker patient: a case report [J]. J Bras Nefrol, 2016, 38(4): 473-477.
|
| [20] |
Balafa O, Liapis G, Pavlakou P, et al. "Diabetic nephropathy" in a non-diabetic patient [J]. Pathol Res Pract, 2016, 212(12): 1199-1201.
|
| [21] |
Kusaba T, Hatta T, Sonomura K, et al. Idiopathic nodular glomerulosclerosis: three Japanese cases and review of the literature [J]. Clin Nephrol, 2007, 67(1): 32-37.
|